Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume $2.85 -0.11 (-3.72%) (As of 01:05 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Galmed Pharmaceuticals Short Interest DataGalmed Pharmaceuticals (GLMD) has a short interest of 45,900 shares, representing 3.08% of the float (the number of shares available for trading by the public). This marks a 73.86% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 759,008 shares to cover all short positions.Current Short Interest45,900 sharesPrevious Short Interest26,400 sharesChange Vs. Previous Month+73.86%Dollar Volume Sold Short$153,306.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares640,000 sharesFloat Size1,490,000 sharesShort Percent of Float3.08%Today's Trading Volume35,750 sharesAverage Trading Volume759,008 sharesToday's Volume Vs. Average5% Short Selling Galmed Pharmaceuticals? Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGLMD Short Interest Over TimeGLMD Days to Cover Over TimeGLMD Percentage of Float Shorted Over Time Ad DTIMan behind OpenAI makes shocking new betBillionaire Sam Altman has become one of the most powerful men in the world by running OpenAI… But there’s a far lesser known investment he’s making that could put OpenAI to shame. In fact this Sam Altman-backed company could actually become a crucial partner for OpenAI… And the US Military… not to mention hundreds of other giant companies around the globe. To make the story even crazier… this company only recently became viable, thanks to an obscure piece of legislation that President Trump signed before he left office… Which ordered the government to take this incredible new technology seriously.Check out our report right here. Galmed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202445,900 shares $153,306.00 +73.9%3.1%0 $3.34 10/15/202426,400 shares $103,488.00 -22.8%1.8%0 $3.92 9/30/202434,200 shares $234,612.00 +9.6%2.3%0 $6.86 9/15/202431,200 shares $128,232.00 -23.2%5.0%0 $4.11 8/31/202440,600 shares $137,228.00 +235.5%6.6%0.8 $3.38 8/15/202412,100 shares $3,628.79 +17.5%0.2%0 $0.30 Get the Latest News and Ratings for GLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202410,300 shares $3,166.22 +14.4%0.2%0.2 $0.31 7/15/20249,000 shares $2,723.40 +1,185.7%0.2%0.2 $0.30 6/30/2024700 shares $192.50 -94.9%0.0%0 $0.28 6/15/202413,700 shares $4,557.99 -42.4%0.2%0.1 $0.33 5/31/202423,800 shares $8,808.38 -67.3%0.4%0.1 $0.37 5/15/202472,800 shares $27,918.80 -13.1%1.3%0.4 $0.38 4/30/202483,800 shares $29,497.60 +6.1%1.5%0.4 $0.35 4/15/202479,000 shares $30,012.10 +101.5%2.2%0.4 $0.38 3/31/202439,200 shares $13,574.96 +532.3%1.1%0.2 $0.35 3/15/20246,200 shares $1,891.62 -84.9%0.2%0 $0.31 2/29/202441,000 shares $16,322.10 -46.1%1.2%0.4 $0.40 2/15/202476,000 shares $28,887.60 +560.9%2.1%0.6 $0.38 1/31/202411,500 shares $4,311.35 -79.1%0.3%0.1 $0.37 1/15/202455,100 shares $25,015.40 -9.7%1.5%0.3 $0.45 12/31/202361,000 shares $27,755.00 +65.3%1.7%0.4 $0.46 12/15/202336,900 shares $13,165.92 -56.9%1.0%0.2 $0.36 11/30/202385,700 shares $30,423.50 +564.3%2.4%0.4 $0.36 11/15/202312,900 shares $5,160.00 +17.3%0.4%0.1 $0.40 10/31/202311,000 shares $4,180.00 -1.8%0.3%0.2 $0.38 10/15/202311,200 shares $4,592.00 +75.0%0.3%0.1 $0.41 9/30/20236,400 shares $3,968.00 +88.2%0.2%0 $0.62 9/15/20233,400 shares $2,515.66 -52.8%0.1%0 $0.74 8/31/20237,200 shares $5,824.80 -32.7%0.2%0 $0.81 8/15/202310,700 shares $8,669.14 -61.1%0.3%0 $0.81 7/31/202327,500 shares $31,625.00 -92.3%1.5%0.1 $1.15 7/15/2023357,100 shares $517,795.00 +2,668.2%20.1%1.3 $1.45 6/30/202312,900 shares $37,539.00 -6.5%0.9%0.1 $2.91 6/15/202313,800 shares $51,474.00 -14.3%1.0%0.5 $3.73 5/31/202316,100 shares $74,221.00 -18.7%1.1%0.7 $4.61 5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00 4/30/202317,200 shares $5,332.00 -6.5%0.1%0.1 $0.31 4/15/202318,400 shares $5,704.00 -30.3%0.1%0.3 $0.31 3/31/202326,400 shares $11,259.60 -28.5%0.1%0.3 $0.43 3/15/202336,900 shares $17,239.68 +58.4%0.2%0.3 $0.47917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today 2/28/202323,300 shares $11,184.00 -32.1%0.1%0.2 $0.48 2/15/202334,300 shares $20,923.00 +106.6%0.2%0.2 $0.61 1/31/202316,600 shares $10,974.26 -88.4%0.1%0.1 $0.66 1/15/2023143,500 shares $115,058.30 -2.3%0.7%1.1 $0.80 12/30/2022146,900 shares $73,450.00 +57.3%0.7%1.3 $0.50 12/15/202293,400 shares $27,086.00 +233.6%0.4%1.1 $0.29 11/30/202228,000 shares $8,173.20 +53.0%0.1%0.8 $0.29 11/15/202218,300 shares $6,101.22 -45.9%0.1%0.4 $0.33 10/31/202233,800 shares $12,847.38 +80.8%0.2%0.6 $0.38 10/15/202218,700 shares $7,264.95 +22.2%0.1%0.3 $0.39 9/30/202215,300 shares $4,759.59 -57.5%0.1%0.2 $0.31 9/15/202236,000 shares $16,563.60 -35.5%0.2%0.4 $0.46 8/31/202255,800 shares $25,896.78 +234.1%0.3%0.5 $0.46 8/15/202216,700 shares $7,424.82 -34.0%0.1%0.2 $0.44 7/31/202225,300 shares $12,703.13 -29.3%0.1%0.2 $0.50 7/15/202235,800 shares $21,651.84 -66.4%0.2%0.3 $0.60 6/30/2022106,600 shares $69,290.00 -0.7%0.5%0.9 $0.65 6/15/2022107,300 shares $48,285.00 +364.5%0.5%1.1 $0.45 5/31/202223,100 shares $11,817.96 -0.4%0.1%0.2 $0.51 5/15/202223,200 shares $14,105.60 -27.3%0.1%0.3 $0.61 4/30/202231,900 shares $52,954.00 -37.6%0.2%0.4 $1.66 4/15/202251,100 shares $83,293.00 -6.2%0.2%0.9 $1.63 3/31/202254,500 shares $86,655.00 -47.3%0.3%0.5 $1.59 3/15/2022103,500 shares $127,305.00 -36.0%0.5%0.8 $1.23 2/28/2022161,700 shares $232,848.00 -30.9%0.8%1.2 $1.44 2/15/2022234,100 shares $374,560.00 -17.9%1.1%1.7 $1.60 1/31/2022285,200 shares $462,024.00 +21.7%1.3%1.8 $1.62 1/15/2022234,300 shares $374,880.00 +20.5%N/A1.3 $1.60 12/31/2021194,400 shares $353,808.00 -36.4%1.0%1.1 $1.82 12/15/2021305,500 shares $653,770.00 +7.0%1.5%2.5 $2.14 11/30/2021285,600 shares $719,712.00 -15.6%1.4%2.4 $2.52 11/15/2021338,500 shares $1.01 million +24.6%1.7%2.7 $2.98 10/29/2021271,700 shares $671,099.00 -16.9%1.3%2.2 $2.47 10/15/2021326,900 shares $898,975.00 +2.7%1.6%1.4 $2.75 9/30/2021318,300 shares $888,057.00 -17.0%1.6%1.4 $2.79 9/15/2021383,700 shares $1.12 million -10.8%1.9%1.6 $2.91 8/31/2021430,100 shares $1.41 million -8.0%2.1%1.7 $3.27 8/13/2021467,500 shares $1.38 million -28.5%2.3%1.4 $2.95 7/30/2021654,000 shares $1.63 million +0.8%3.3%1.8 $2.49 7/15/2021648,700 shares $1.69 million -0.6%3.2%2.4 $2.61 6/30/2021652,500 shares $1.98 million +23.6%3.3%2.3 $3.04 6/15/2021527,900 shares $1.68 million +97.9%2.6%1.8 $3.18 5/28/2021266,800 shares $693,680.00 -1.4%1.3%0.8 $2.60 5/14/2021270,700 shares $606,368.00 -16.4%1.4%1 $2.24 4/30/2021323,900 shares $1.09 million -2.4%1.6%0.8 $3.37 4/15/2021331,700 shares $1.09 million +15.1%1.7%0.8 $3.30 3/31/2021288,300 shares $960,039.00 +30.2%1.5%0.7 $3.33 3/15/2021221,500 shares $775,250.00 +14.8%1.1%0.5 $3.50 2/26/2021192,900 shares $792,819.00 +389.6%1.1%0.5 $4.11 2/12/202139,400 shares $212,760.00 +4.2%0.2%0.1 $5.40917 Trades… Zero Losses? (Ad)As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today 1/29/202137,800 shares $142,695.00 +49.4%0.2%0.2 $3.78 1/15/202125,300 shares $88,044.00 -22.6%0.2%0.2 $3.48 12/31/202032,700 shares $106,929.00 +26.3%0.2%0.3 $3.27 12/15/202025,900 shares $94,794.00 -29.0%0.2%0.3 $3.66 11/30/202036,500 shares $152,205.00 +55.3%0.2%0.5 $4.17 11/15/202023,500 shares $79,665.00 +109.8%0.2%0.3 $3.39 10/30/202011,200 shares $34,384.00 -49.6%0.1%0.2 $3.07 10/15/202022,200 shares $74,370.00 -53.0%0.1%0.3 $3.35 9/30/202047,200 shares $166,616.00 -28.9%0.3%0.5 $3.53 9/15/202066,400 shares $278,880.00 -65.2%0.4%0.8 $4.20 8/31/2020191,000 shares $932,080.00 -56.7%1.2%2.3 $4.88 8/14/2020441,500 shares $2.09 million -3.0%2.8%5.1 $4.74 7/31/2020455,100 shares $2.21 million -2.5%2.9%4.6 $4.85 7/15/2020466,700 shares $2.20 million +0.3%3.2%5.2 $4.72 6/30/2020465,500 shares $2.25 million +23.8%3.2%5.8 $4.84 6/15/2020376,000 shares $1.85 million +1.1%2.5%4.5 $4.92 5/29/2020372,000 shares $1.77 million -4.6%2.5%4 $4.75 5/15/2020389,900 shares $1.98 million +3.5%2.6%4 $5.09 4/30/2020376,900 shares $1.64 million -0.3%2.6%4.5 $4.36 4/15/2020378,200 shares $1.62 million +1.3%2.6%4.2 $4.29 3/31/2020373,300 shares $1.69 million +0.6%2.5%4 $4.53 3/13/2020371,000 shares $1.37 million -10.4%2.5%4.1 $3.68 2/28/2020414,100 shares $1.51 million -1.4%2.7%4.6 $3.64 2/14/2020420,000 shares $2.10 million +4.1%2.9%3.7 $4.99 1/31/2020403,600 shares $2.16 million -7.2%2.7%3.7 $5.36 1/15/2020434,700 shares $2.52 million -4.7%3.0%3.8 $5.79 12/31/2019455,900 shares $2.63 million -2.1%3.1%4 $5.77 GLMD Short Interest - Frequently Asked Questions What is Galmed Pharmaceuticals' current short interest? Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 45,900 shares of GLMD short. 3.08% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest. What is a good short interest percentage for Galmed Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.08% of Galmed Pharmaceuticals' floating shares are currently sold short. Is Galmed Pharmaceuticals' short interest increasing or decreasing? Galmed Pharmaceuticals saw a increase in short interest in the month of October. As of October 31st, there was short interest totaling 45,900 shares, an increase of 73.9% from the previous total of 26,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Galmed Pharmaceuticals' float size? Galmed Pharmaceuticals currently has issued a total of 640,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 1,490,000 shares. How does Galmed Pharmaceuticals' short interest compare to its competitors? 3.08% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies compare to Galmed Pharmaceuticals: Eyenovia, Inc. (3.34%), Syros Pharmaceuticals, Inc. (6.35%), Biora Therapeutics, Inc. (4.76%), Brainstorm Cell Therapeutics Inc. (2.27%), Edesa Biotech, Inc. (0.75%), GT Biopharma, Inc. (0.90%), Evoke Pharma, Inc. (7.43%), ABVC BioPharma, Inc. (1.77%), Adial Pharmaceuticals, Inc. (1.25%), Cardio Diagnostics Holdings, Inc. (7.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Galmed Pharmaceuticals stock? Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. GLMD shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Galmed Pharmaceuticals? A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further. How often is Galmed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Aptorum Group Short Interest Data Brainstorm Cell Therapeutics Short Interest Data Biora Therapeutics Short Interest Data ABVC BioPharma Short Interest Data Evoke Pharma Short Interest Data Edesa Biotech Short Interest Data GT Biopharma Short Interest Data Eyenovia Short Interest Data TransCode Therapeutics Short Interest Data Adial Pharmaceuticals Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GLMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
